Jean-Paul FEVRE

About Jean-Paul FEVRE

Jean-Paul FEVRE is the founder and long-standing chief executive of Plant Advanced Technologies PAT, a French plant-biotechnology company listed on Euronext Growth. He has held the combined roles of Chairman of the Board and Chief Executive Officer since at least 2009, placing him at the center of the group’s strategy, governance, industrial development, and capital structure. His professional identity is closely tied to PAT’s creation, growth, and positioning as an innovative company focused on plant-derived molecules. Under his leadership, PAT developed a distinctive model at the intersection of research, innovation, and industrial execution. The company built its business around advanced technologies for extracting and producing high-value natural compounds for cosmetics, pharmaceuticals, and health-related markets. Jean-Paul FEVRE’s role has been to guide the transformation of a scientific concept into an industrial platform capable of attracting partners, securing funding, and supporting sustainable corporate growth. Available sources also indicate that he played a central role in PAT’s market listing and in the organization of its shareholder base. Listing documents refer to his involvement in the company’s early market access, while more recent disclosures show that he remains a key figure in PAT’s ownership and long-term stability. In 2022, a collective shareholding commitment involving Jean-Paul FEVRE and close shareholders further highlighted his commitment to reinforcing the company’s capital continuity and strategic consistency. His expertise sits at the crossroads of corporate strategy, deep-tech innovation, and the governance of listed small and mid-cap companies. Jean-Paul FEVRE is therefore seen as an entrepreneurial leader capable of sustaining a long-term vision, monetizing a differentiated technology asset, and maintaining industrial discipline in a demanding environment. His career illustrates how a founder can turn a scientific innovation into a market-facing company with a clear focus on value creation, intellectual property, and stock-market credibility.